The Oral Fluid (saliva) test will detect the presence of drugs and can confirm the exact type of drug found, using UKAS 17025 accredited methods.
This test option is an effective way of determining recent drug use, with initial screening results being available within 2 working days of sample collection. When required, confirmation testing of non-negative screen results are available within a further 3 to 5 working days.
The Standard panel of 5 drug groups is listed below:
- Amphetamines, including Methamphetamine and Ecstasy (MDMA)
- Benzodiazepine (including Diazepam and Temazepam)
The Laboratory test can be combined with a Breath Alcohol Screen to meet your testing requirements.
Each donor is legally identified at the appointment, oral fluid samples are then collected, sealed and bar coded to strict Chain of Custody Protocols following EWDTS guidelines. Samples are then processed to our UKAS 17025 and ILAC accredited laboratory for analysis.
The analysis is performed against predefined cut-off levels for all drugs tested.
Laboratory reports are generated and issued for all samples that screen negative. Initial screening takes up to 2 working days from the appointment, however, reports are usually available the day following sample collection.
Samples that screen non-negative are issued with a ‘Undergoing Further Analysis’ report and require additional Confirmation Testing. Confirmation Testing is required to identify the drug or metabolite found in the sample and the quantity present. If a drug is detected above this cut off level then a positive report will be issued.
Dependant on the circumstances, the laboratory report may specify whether the drug and its quantity can be deemed therapeutic i.e. in line with medication already declared by the donor. Further investigation to confirm this can be undertaken by utilising the Medical Review Service.
Follow the useful links below for more information about the Oral Fluid Drug Test.